Oncology, answered.

Flatiron Health answers oncology's toughest questions by learning from the experience of every person with cancer.

We combine high-fidelity data with AI that's powered by human expertise. That means faster answers, stronger decisions, and better outcomes for every patient.

Explore our solutions:

For Life Sciences For the Point of Care

Global oncology data network coverage map

Every patient story shapes the next

Our global oncology engine captures data from millions of cancer patients around the world, directly at the source, and transforms it into actionable insights across the entire oncology ecosystem.

Flatiron real-world data has informed 2,000+ publications—and counting

Explore the impact of our real-world evidence

From plenary to practice: A large language model (LLM)-based thematic analysis of landmark clinical trial discussions and factors influencing their real-world adoption

ASCOMay 2026

Real-world biomarker testing rates, targeted therapy use, and clinical outcomes in patients with advanced gastric or GEJ cancer in the United States

ASCOMay 2026

Using ML to predict rapid progression for patients (pts) with HR+/HER2- metastatic breast cancer (mBC) treated with frontline (1L) CDK 4/6 inhibitors (CDK 4/6i)

ASCOMay 2026

More publications

Explore our impact in oncology

More news, research and resources

See our research at upcoming industry events

May 29 – June 2, 2026

Chicago, IL

Booth #21149

49+ research acceptances

EHA 2026 Congress

June 11 – June 14, 2026

Stockholm, Sweden

ISPE 2026

August 29 – September 2, 2026

Milan, Italy

More upcoming events

Move forward with confidence